title: Rh isoimmunization during pregnancy: antenatal prophylaxis.
abstract: Of 3533 Rh-negative women who began a pregnancy without detectable Rh antibodies, 62 (1.8%) demonstrated evidence of Rh isoimmunization during pregnancy or within 3 days after delivery. All denied transfusions as well as abortions or previous pregnancies not followed by the administration of Rh immune globulin. Rh isoimmunization during pregnancy or within 3 days after delivery, which will not be prevented by the administration of Rh immune globulin after delivery, is the most important cause of residual Rh isoimmunization. A clinical trial of antenatal administration of Rh immune globulin, initially at 34 weeks's and subsequently at 28 and 34 weeks' gestation, in 1357 Rh-negative pregnant women who were delivered of Rh-positive babies, was effective in preventing the development of Rh isoimmunization during pregnancy or within 3 days after delivery. Antenatal prophylaxis  with Rh immune globulin will be necessary if the incidence of Rh isoimmunization is to be reduced to its lowest possible level. Antenatal prophylaxis at 28 weeks' gestation is now an insured service in Manitoba.
mesh_terms: D000917:Antibody Formation; D001787:Blood Group Incompatibility / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007518:Isoantibodies / Q000032:analysis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System; D013997:Time Factors; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins